Skip to main content
Oncology PM & RCM Software

The Leading Practice Management and RCM Billing Software for Oncology

Connect treatment workflows, specialty billing rules, and reimbursement on one platform built for cancer care. Learn why Unlimited Systems is the trusted choice for Oncology practice management and RCM software.

Why oncology billing is different

Community oncology carries financial risk that general practice management software was never designed for. A single treatment day can combine a high-cost biologic, an administration sequence billed by the minute, a payer-specific step-therapy requirement, and discarded drug that has to be documented to be paid for.

When those details live in separate systems, the gaps show up as denied J-codes, unbilled wastage, expired authorizations, and drug margin no one can explain until the month closes. Oncology-specific rules and connected data are what keep those exceptions from becoming write-offs.

★★★★★4.8/5G2★★★★★5/5Gartner★★★★★5/5
6,500+ specialty providersSOC 2 certified
Caregiver holding a patient's hands in reassurance

Product screenshot

Oncology workspace preview coming soon

Trusted Payer & EHR Integration Partners

Integration partner 1Integration partner 2Integration partner 3Integration partner 4Integration partner 5Integration partner 6Integration partner 7Integration partner 8Integration partner 9Integration partner 10
6,500+
providers nationwide
Over 50%
of US community oncology groups
$70B+
in claims processed annually

Designed Around How Your Oncology Practice ACTUALLY Works

Our connected workflows are built to make you and your work easier to do and increase your revenue.

Treatment-ready

Keep regimen authorization and coverage aligned before the chair is booked.

Claim-ready

Validate J-codes, dose details, and JW/JZ modifiers before submission.

Practice-ready

Give teams one view of denials, drug margin, and A/R priorities.

Specialty RCM intelligence

Oncology Revenue Cycle Challenges

Highest buy-and-bill complexity in any specialty.

22%
Est. denial rate
10/10
Prior-auth burden

Where revenue is at risk

Chemotherapy Drug Billing

HCPCS J-codes for high-cost agents; ASP+6% margin compression under Medicare; biosimilar substitution rules.

How the platform addresses this

  • J-code and NDC pairs are validated against the documented regimen before submission.
  • ASP-based fee schedules are modeled per payer, so margin compression is visible at order entry.
  • Biosimilar and reference-product substitutions update the charge automatically.
See it on your own claims
Buy-and-bill drug reference5 agents · codes, channel, prior-auth, and billing notes
DrugCodeRouteChannelCostPABilling notes
Keytruda (pembrolizumab)J9271IVPart B$180K/yrYesSingle-dose vial; JW required.
Opdivo (nivolumab)J9299IVPart B$150K/yrYesWeight-based dosing complexity.
Herceptin (trastuzumab)J9355IV/SQPart B$70K/yrYesBiosimilar pressure from Kanjinti and Ogivri.
Avastin (bevacizumab)J9035IVPart B$55K/yrYesMulti-use; partial vial tracking is critical.
Zometa (zoledronic acid)J3489IVPart B$2K/yrSometimesGeneric available; AWP vigilance needed.

Cabinet integration: Cabinet-to-EHR integration is critical because oncology practices may stock 30-60+ J-code drugs. Without ADC integration, partial-vial charge capture and wastage documentation gaps become a primary source of revenue leakage.

Your EHR and revenue cycle, connected

Move schedules, patient data, and charge details without duplicate entry.

Physician reviewing results at an office workstation
Bi-directional connection

Flatiron OncoEMR

Therapy documentation and financial workflow exchange.

What better oncology workflows look like

Less manual work, clearer margin, and faster follow-up.

Midwest Cancer Care Associates, oncology case study

Midwest Cancer Care Associates

Columbus, OH18-physician oncology group
JW/JZ and J-code edits recovered revenue we used to write off each month.

- Director of Revenue Cycle

26%
Fewer drug denials
$2.1M
Wastage revenue recovered

One platform for every oncology workflow

Eight connected capabilities, grouped around the way your practice works.

Financial performance dashboards on an office laptop
1.25%of drug spend typically left in waste

Challenges we solve for oncology

The work that generic platforms leave to your staff is the work oncology margin actually turns on.

Drug waste reconciled by hand after every infusion
Dose-to-vial rules apply JW/JZ before filing
Regimen authorizations tracked in portals and spreadsheets
Auth status stays tied to the regimen and the chair
Biosimilar swaps billed under the wrong reference code
Reference and biosimilar codes mapped at the charge
Drug margin only visible after the month closes
Acquisition-to-payment margin by regimen and payer

Built for oncology, not adapted to it

Compare the capabilities that matter most in buy-and-bill care.

CapabilityUnlimited FinancialsGeneral platforms
JW/JZ waste automationBuilt inOften manual
Oncology dose validationPreconfiguredCustom setup
Bi-directional EHR exchangeSupportedVaries
Oncology billing guidanceIncludedGeneral support

Need to compare a specific workflow?

Estimate your oncology RCM opportunity

Adjust three inputs to see an illustrative annual impact range.

Clinic profile inputs

Adjust the inputs to match your practice.

8
$350,000
Oncology biologics average high-value claims ($2,500+ per unit-dose infusion cycle).
12%

See your oncology ROI

Enter your work email to unlock your estimated annual financial impact.

See Your Results ImmediatelyGoogle5/5Gartner5/5G24.8/5
Still evaluating

Plan the decision before renewal pressure

A focused workflow review can show what to keep, what to fix, and whether a change is worth planning.

High Quality Support System representing Unlimited Systems Support Team

Start with a workflow review. We map J-codes, JW/JZ rules, authorizations, interfaces, and payer requirements before a transition is proposed.

Less billing work between treatment and payment

Specialty rules and connected data keep your team focused on the exceptions that need judgment.

Verify before treatment

Coverage and authorization stay tied to the regimen.

Validate specialty charges

Dose, vial, and modifier checks happen before filing.

Work the right accounts

Denials and A/R are ranked by value and filing risk.

Oncologist speaking with a patient during a cancer care visit
35%less manual workflow time

See the Medicare rules for your state

Preview the MAC jurisdiction and oncology checks mapped into the workflow.

Medicare contractor

CGS Administrators

J15
Rule check
JW/JZ waste rules
Coverage policy
LCD L34028 · chemotherapy administration

Oncology billing questions

Most bi-directional integrations take 6–12 weeks, including workflow mapping, testing, and cutover support.

AI + Automation

AI & Automation for Oncology

  • Automatic JW/JZ drug-waste modifier capture at charge entry.
  • Chemo-regimen prior authorization checked before the visit, not after.
  • NCD/LCD medical-necessity rules validated automatically before submission.
  • Work by exception surfaces only the regimens with an actual risk.
Explore AI for Oncology

We Love Hearing From Our Users

Oncology and specialty practices, on what changed after moving to Unlimited Financials.

★★★★★4.8/5G2
★★★★★5/5Gartner

I'd love to set up a call to talk about SCOA, and the success we've had with Unlimited Financials.

Sam Wheeler
CFO, SCOA

The system continues to grow with features as it should, with how healthcare changes. So, if you are looking for a company that is innovative and truly cares, I would recommend Unlimited Financials.

Ernelita Dacumos
Billing Manager, SHOM

Unlimited Financials has been the easiest and best practice management system I have used. It is easy to navigate and do what I need to do.

Melissa Shook
Medical Biller, SHOM

I would recommend Unlimited Financials to other specialty practices.

Michelle Leandri
CEO, NEPA

We transitioned to Unlimited Financials in 2024... the team and platform are absolutely amazing.

Gina
Administrator, FOUR

We have been on Unlimited Financials for over three years and love it. Our claims are being processed faster and more efficiently, which means we are receiving payment more quickly.

Renee Bernacchi
Accounts Receivable Coordinator, COAS

GET STARTED

Optimize Your Oncology Revenue Cycle

Connect with an oncology RCM expert for a personal workflow walkthrough, and see where your current setup is creating avoidable revenue risk.

★★★★★4.8/5G2★★★★★5/5Gartner★★★★★5/5
6,500+ specialty providersSOC 2 certified